Schwob E, Hagos Y, Burckhardt G, Burckhardt BC. Transporters involved in renal excretion of N-carbamoylglutamate, an orphan drug to treat inborn n-acetylglutamate synthase deficiency.
hyperammonemia; dicarboxylates; organic anion transport AMMONIUM IONS (NH 4 ϩ ) are produced by the catabolism of protein and nitrogen-containing compounds. NH 4 ϩ exhibits toxic effects by altering several amino acid and neurotransmitter pathways, leading to severe neurological symptoms. Especially in the developing brain, high NH 4 ϩ blood levels provoke cortical atrophy, ventricular enlargement, demyelination, and changes in gray and white matter densities (1, 4, 5, 8) . To avoid these toxic effects, NH 4 ϩ is normally converted into nontoxic urea by the urea cycle in hepatocytes. Urea cycle disorders are, if not acquired by liver cirrhosis or other liver diseases, inborn errors of one of the following urea cycle enzymes: carbamoylphosphate synthase 1 (CPS1), ornithine transcarbamylase, argininosuccinate synthase, argininosuccinate lyase, and arginase 1. Although N-acetylglutamate (NAG) synthase (NAGS) is not a urea cycle enzyme per se, it catalyzes the formation of NAG from the precursors glutamate and acetyl CoA (9) . NAG is an essential cofactor for activating CPS1. The orphan drug N-carbamoylglutamate (NCG; carglumic acid, Carbaglu), a stable synthetic derivative of glutamic acid and a structural homolog of NAG (Table 1) , has been approved in the United States and European Union for the treatment of urea cycle disorders due to NAGS deficiency and related urea cycle disorders (12, 14, 15, 25) .
Despite the beneficial effects of NCG in overcoming NAGS deficiency, information regarding its intestinal and hepatic uptake and its renal excretion is scarce. Available data from its briefing document are the time to peak plasma concentration at 3 h after oral application, with peak plasma concentrations varying between 1.8 and 4.8 g/ml, and a renal clearance of 204 -445 ml/min (26a), indicating uptake and excretion by specific transport systems. Because NCG is a glutamate derivative with a dicarboxylic-like structure and is a divalent organic anion at physiological pH (Table 1) , it could be a candidate substrate of sodium-dependent di-and tricarboxylate transporters of the SLC13 transporter family (for reviews, see Refs. 2 and 27). Sodium-dependent dicarboxylate cotransporter 3 (NaDC3; gene name SLC13A3) is present in proximal tubule cells, hepatocytes, and astrocytes and accepts dicarboxylates, mainly ␣-ketoglutarate and other glutarate derivatives, such as 3-hydroxyglutarate (26), or modified amino acids, such as N-acetyl-L-aspartate (19) . Sodium-citrate transporter (NaCT; gene name SLC13A5), another member of this family, is present in the kidneys, liver, and neurons and transports mainly citrate (13, 20) . NaDC3 is tightly linked to organic anion transporters (OATs) (for reviews, see Refs. 7, 23, 24, 29, 30, and 32) , which are known to transport not only drugs such as antibiotics, antihypertensives, antivirals, cytostatics, diuretics, and sartanes but also interact with dicarboxylates (21) . Up to now, OATs have not been identified in the small and large intestine (with the exception of OAT2 and OAT3) or in the liver. Organic anion-transporting polypeptides (OATPs) accept a wide variety of structurally unrelated drugs similar to those also accepted by OATs and are expressed in the small intestine, liver, and kidneys (16, 23, 29, 30) .
The aim of the present study was to identify transporters interacting with NCG. Therefore, the impact of NCG on several human OATs and OATPs stably transfected in human embryonic kidney (HEK)-293 cells and of two human members of the SLC13 transporter family, NaDC3 and NaCT, expressed in Xenopus laevis oocytes was investigated by tracer uptake and electrophysiological methods, respectively.
MATERIALS AND METHODS
Reagents and chemicals. Chemicals used in the uptake and electrophysiological experiments, including the constituents of mammalian (MRi) and oocyte Ringer (ORi) solutions and the test substrates ␣-ketoglutarate, citrate, cyclosporine, estrone-3-sulfate (ES), glutamate, glutarate, indomethacin, NAG, NCG, p-aminohippurate (PAH), probenecid, rifampicin, succinate, and the antibiotics penicillin-streptomycin, blasticidine, and gentamycin, were purchased from SigmaAldrich (Taufkirchen, Germany) or AppliChem (Darmstadt, Germany). All radiochemicals were purchased from Perkin-Elmer (Rodgau, Germany).
Cell culture and transport experiments. OAT2, OATP1B1, OATP1B3, OATP2B1, and sodium-taurocholate transporter were obtained from PortaCellTec Biosciences (Göttingen, Germany). All stably transfected HEK-293 cells were grown in flasks coated with 0.1 mg/ml poly-L-lysine in high-glucose DMEM (Invitrogen) supplemented with 10% FCS (European Union-approved origin, Invitrogen), 1% penicillin-streptomycin, and 5 mg/l blasticidine. Control cells were transfected with the vector alone. Cultures were maintained in a humidified atmosphere that contained 5% CO 2 at 37°C. Transporterand vector-transfected HEK-293 cells were harvested and plated into 24-well plastic dishes (Sarstedt, Nürmbrecht, Gemany) at a density of 2 ϫ 10 5 cells/well. At the end of the 72-h culture, cells were washed twice with 0.5 mL MRi, which contained (in mM) 130 NaCl, Table 2 . Uptake was terminated by removal of the radiolabeled medium and three immediate 1-ml washes with ice-cold MRi. Cells were dissolved in 0.5 ml of 1 N NaOH by gently shaking for 120 min, and 3 H content was determined by liquid scintillation counting (Tricarb 2900TR, Perkin-Elmer). To determine the concentration of half-maximal inhibition (IC 50) of CCK8 uptake by NCG or of PAH uptake by NCG and glutamate, NCG concentrations from 0 to 1,000, and glutamate concentrations from 330 to 5,000 M were applied simultaneously with the radiolabeled reference substrate, respectively. In these experiments, counts obtained in vector-transfected HEK-293 cells were subtracted from counts in transportertransfected cells to obtain transporter-mediated uptake. For transstimulation experiments, either OAT1-, OAT4-, or vector-transfected HEK-293 cells were incubated at 37°C for 120 min in MRi containing 5 mM NCG (pH 7.4). Thereafter, cells were washed two times in MRi, and the uptake of radiolabeled PAH (OAT1) and ES (OAT4) was measured. To visualize the passive diffusion of NCG during the 120-min incubation period, counts of vector-transfected cells were not subtracted from those of transporter-transfected cells, and the results are shown in separate columns (see Fig. 3 , A and B).
In vitro transcription of human NaDC3 and NaCT cRNA. Plasmids from human NaDC3 and NaCT (Genbank Accession Numbers AF154121 and AY151833) were linearized with NotI, and in vitro cRNA transcription was performed using the T7 mMessage mMachine kit (Ambion, Austin, TX) according to the manufacturer's instructions. The resulting cRNA was suspended in purified RNAse-free water to a final concentration of 1 g/l.
Oocyte preparation, storage, and electrophysiological analysis. The use of oocytes from X. laevis was approved by the government of Lower Saxony. For all experiments with oocytes, ORi was used, which contained (in mM) 110 NaCl, 3 KCl, 2 CaCl2, 5 and HEPESTris. Na ϩ -free conditions were achieved by replacing Na ϩ by equimolar concentrations of N-methyl-D-glucamine (NMDG). Succinate, citrate, glutamate, NAG, and NCG were added to ORi in the concentrations indicated in the figures, and pH was always adjusted to pH 7.5. Stage V and VI oocytes from X. laevis (Nasco, Fort Atkinson, WI) were separated by an overnight treatment with collagenase (Typ CLS II, Biochrom, Berlin, Germany), subsequently washed in Ca 2ϩ -free ORi, and maintaining again in ORi with 2 mM Ca 2ϩ . One day after removal from the frog, oocytes were injected with 23 nl cRNA coding for NaDC3, NaCT, or an equivalent amount of RNAse-free water. After 3 days of incubation at 16 -18°C in ORi supplemented with 50 M gentamycin and 2.5 mM sodium pyruvate (Sigma) with daily medium changes, oocytes were used for the electrophysiological experiments. In these experiments, oocytes were placed into a 0.5 ml-chamber on the stage of an inverted microscope and impaled under direct view with borosilicate glass microelectrodes filled with 3 M Data are means Ϯ SE of at least two experiments from consecutive cell passages. Data represent substrate-mediated uptake, i.e., uptake in vector-transfected human embryonic kidney-293 cells was subtracted from uptake measured in transporter-transfected cells. All substrates were labeled with 3 H. "Substrate" indicates the total substrate concentration (labeled and unlabeled). Significant differences in uptakes in the absence (control) and presence of 500 M NCG (ϩNCG) or or an inhibitor specific for the respective transporter (ϩselective inhibitor) were determined by an unpaired Student's t-test (*P Ͻ 0.001). †In the case of OAT3, a surplus of unlabeled estrone-3-sulfate (ES) was used as an inhibitor. OATP, organic anion-transporting polypeptide; OAT, organic anion transporter.
KCl (BioMedical Instruments, Zöllnitz, Germany). Using the twoelectrode voltage-clamp device (OC725A, Warner, Hambden, CT) in the voltage-clamp mode, substrate-mediated currents were detected at a clamp potential of Ϫ60 mV. Current-voltage relations were obtained by changing the clamp potential for 10 s in 10-mV steps in the presence and absence of succinate or NCG (5 mM dissolved in ORi). Substrate-mediated currents were calculated by subtraction of the currents in the absence of substrate from those measured in the presence of substrate.
Statistics and calculations. Data are provided as means Ϯ SE. Unpaired Student's t-tests were used to show statistical significant differences for the inhibition of uptake of either CCK8, PAH, cGMP, or ES by several inhibitors on transporter-transfected HEK-293 cells. A paired Student's t-test was used in experiments with X. laevis oocytes where the currents derived in the absence and presence of a compound could be obtained on the same oocyte. In the electrophysiological as well as tracer uptake experiments, statistical significance was set at P Ͻ 0.001. Michaelis-Menten constants (K m) for succinate, glutarate, ␣-ketoglutarate, NCG, NAG, and glutamate and IC50 values of PAH uptake by NCG and glutamate were calculated using SigmaPlot software (Systat Software, Point Richmond, CA).
RESULTS
Transporters for organic anions possibly involved in the uptake of NCG. Several intestinal, hepatic, and renal transporters for organic anions were tested for their interaction with NCG. Therefore, the uptake of the respective reference substrate of each transporter was measured in the absence or presence of a typical inhibitor and in the absence or presence of NCG (Table 2 ). All transporters showed uptake of their reference substrate and a significant inhibition of this uptake by a specific inhibitor. Among the OATPs and OATs tested, only the uptake of CCK8 in OATP1B3-transfected HEK-293 cells and uptake of PAH in OAT1-transfected HEK-293 cells was significantly reduced by NCG (by 27.7 Ϯ 13.7 and 71.1 Ϯ 2.5%, respectively). Because the inhibition of CCK8 uptake by 500 M NCG in OATP1B3-transfected HEK-293 cells was only partial even at NCG concentrations exceeding 1,000 M, this transporter was not investigated further. The uptake of PAH in OAT1-transfected HEK-293 cells was inhibited by NCG with an IC 50 of 202.8 Ϯ 22.7 M (Fig. 1A) and by structurally related glutamate with an IC 50 of 638.2 Ϯ 82.7 M (Fig. 1B) .
Interactions (Fig. 2) , suggesting competition between NCG and PAH. Trans-stimulation experiments were performed by preincubation of OAT1-transfected HEK-293 cells for 120 min in MRi containing additional 5 mM NCG. Uptake of PAH increased from 37.0 Ϯ 3.2 to 56.4 Ϯ 5.2 pmol·min Ϫ1 ·mg Ϫ1 upon preload of the cells with NCG, suggesting that NCG is translocated by OAT1 (Fig. 3A) . Preincubation of OAT4-transfected HEK-293 cells for 120 min in MRi containing additional 5 mM NCG stimulated the uptake of ES from 1,123 Ϯ 85 to 1,491 Ϯ 196 fmol·min Ϫ1 ·mg Ϫ1 (Fig. 3B) , suggesting that extracellular ES is taken up into the cells in exchange for intracellular NCG.
Interactions of NCG with Na ϩ -dependent transporters for di-and tri-carboxylates, NaCT, and NaDC3. At a clamp potential of Ϫ60 mV, 1 mM citrate, 5 mM succinate, and 5 mM NCG (all dissolved in ORi) evoked substrate-dependent currents of Ϫ9.7 Ϯ 1.7, Ϫ11.7 Ϯ 1.4, and ϩ1.1 Ϯ 3.1 nA in NaCT-expressing oocytes but not in water-injected control oocytes (4 oocytes from NaCT-expressing oocytes and 3 oocytes from water-injected oocytes). Due to the small currents induced by citrate, NaCT was not investigated further. In NaDC3-expressing oocytes, succinate, glutamate, NAG, and NCG (all at a concentration of 5 mM dissolved in ORi; Fig.  4A ) induced inward currents of similar magnitudes. Substrateassociated currents were not observed in water-injected control oocytes (Fig. 4B) . NCG-associated currents were abolished when Na ϩ was substituted with NMDG (data not shown). In the presence of Na ϩ , substrate-mediated currents decreased upon depolarization of oocytes from Ϫ90 to 0 mV (Fig. 4C) . The potential-dependent currents evoked by NCG (Fig. 4C , solid circles) and by succinate (all at 5 mM dissolved in ORi; Fig. 4C , open circles) were similar in magnitude. Waterinjected control oocytes showed no potential-dependent inward currents (Fig. 4C, solid inverted triangles) .
Besides succinate (Fig. 5A ), NCG-induced (Fig. 5B) , NAGinduced (Fig. 5C) , and glutamate-induced (Fig. 5D ) inward currents exhibited saturations kinetics. K m values were 9.7 Ϯ 2.0 for succinate, 25.7 Ϯ 2.1 for NCG, and 125 Ϯ 10 M for NAG, respectively. The C5-dicarboxylates, glutarate and ␣-ketoglutarate, also showed saturation kinetics from which K m values of 39.7 Ϯ 1.9 and 21.7 Ϯ 9.9 M were calculated. Glutamate turned out to be a poor substrate, with a K m value of 2,517 Ϯ 473 M (Table 3) .
DISCUSSION
Hyperammonemia is a severe metabolic disorder due to the toxicity of NH 4 ϩ for the central nervous system, resulting in developmental delays. If hyperammonemia is caused by a reduction of NAG, an essential cofactor for the initiation of the urea cycle, patients can be successfully treated with NCG (Carbaglu), an analog of NAG that has a direct effect on CPS1, thereby initiating the urea cycle. In contrast to NAG, the physiological allosteric activator of CPS1 (NCG) is more resistant to hydrolysis by the cytosolic aminoacylase (22) . After oral application, most of the drug remains unchanged; a small fraction, however, is metabolized to glutamate and CO 2 , and it is unclear whether hydantoin-5-propionate is a potential metabolite or an impurity of the drug product (26a).
Pharmacokinetic characteristics were investigated in 12 healthy male volunteers (14, 26a) that received 100 mg NCG/kg body wt as a single oral dose. Three hours after NCG administration, free plasma concentrations ranged from 1.8 to 4.8 g/ml.
Given the molecular weight of NCG of 190 g/mol, these values correspond to plasma concentrations between 9.5 and 25 M (calculated from Ref. 26a). The renal clearance up to 445 ml/min indicates strong renal secretion of NCG.
Because OATPs are localized in the gastrointestinal tract as well as in the liver, we considered them as candidate transporters for intestinal and hepatic NCG uptake. OATP1A2 is localized at the apical membrane of enterocytes and distal tubule cells. In the liver, OATP1A2 is present in cholangiocytes; the presence of OATP1B1 and OATP1B3 is restricted to hepatocytes (16) . NCG did not interact with OATP1A2 and OATP1B1 and only marginally with OATP1B3, indicating that these members of the OATP family are most likely not involved in intestinal and hepatic transport of NCG.
OAT2 also did not interact with NCG. This is surprising since OAT2 was recently identified as a bidirectional glutamate transporter leading to glutamate accumulation (28) . Thus, OAT2 most likely does not contribute to hepatic uptake of NCG. In recent studies, we investigated the inhibitory potency of dicarboxylates and their derivatives on substrate uptake in OAT1-and OAT3-transfected HEK-293 cells. Dicarboxylates such as succinate, glutarate, adipate, pimelate, and suberate showed a higher inhibitory potency on OAT1 than on OAT3 (21) . NAG inhibited the uptake of PAH in OAT1-transfected HEK-293 cells, with an IC 50 of 26 Ϯ 3 M, and glutamate was identified as a competitive inhibitor. Both compounds led to an increased uptake of PAH in trans-stimulation experiments, demonstrating transport of NAG and glutamate by OAT1 (17) . OAT3-transfected HEK-293 cells showed only limited interactions with NAG and glutamate (17) . These findings are in line with observations in the present study where, by cisinhibition and trans-stimulation experiments, NCG turned out to be an OAT1 substrate, whereas OAT3 failed to interact with NCG. These data suggest that OAT1 is involved in the uptake of NCG from blood into proximal tubule cells.
In electrophysiological experiments, NCG did not induce measurable currents in NaCT-expressing oocytes. Since the reference substrate of NaCT, citrate, produced only small currents, we cannot conclude or exclude that NCG is transported by NaCT. As opposed to NaCT, NCG turned out to be a substrate transported by NaDC3. NaDC3 accepts a broader range of di-and tricarboxylates, including the heavy metal chelator 2,3-dimercaptosuccinate (6), the neurotransmitter Nacetylaspartate (19), 3-hydroxyglutarate, a metabolite of the inherited metabolic disease glutaric aciduria (26) , and NAG (17) . NCG showed properties typical of a NaDC3 substrate, i.e., Na ϩ dependence and a decrease in substrate-mediated currents by depolarization of the oocyte. The K m value was determined to be 25.7 Ϯ 2.1 M and was in the order of the plasma concentration of NCG (Table 1) . When maximal current-to-K m ratios were compared (Table 3) , NCG, ␣-ketoglutarate, and glutarate were identified as equally effective substrates of NaDC3, whereas NAG and glutamate were weak substrates.
In a previous study (11) , rat NaDC3 mRNA was found to be expressed in hepatocytes surrounding the central vein, indicating that NaDC3 may be associated with glutamine synthesis, exclusively occurring in perivenous hepatocytes. NCG, however, needs to be taken up into periportal hepatocytes, the site of urea synthesis. At this point, we must leave open how NCG reaches the site of action.
In renal proximal tubules, it is likely that NCG is taken up from the blood by NaDC3. To avoid accumulation within the proximal tubule cell, NCG has to leave the cell by a luminal transporter. In a previous study (18) , OAT4 was identified as an asymmetric transporter accepting dicarboxylates only from intracellular side. Therefore, OAT4-transfected HEK-293 cells were preincubated with NCG. This experimental condition led to an increase in ES uptake, indicating that NCG leaves the cell in exchange for extracellular ES. In summary, although intestinal absorption and uptake into periportal hepatocytes could not be clarified, we propose that OAT1 and NaDC3 in the basolateral membrane and OAT4 in the luminal membrane of proximal tubule cells are responsible for the avid renal secretion of NCG observed in humans. Determinations were performed in triplicate and are shown as means Ϯ SE. Km values were determined by application of increasing concentrations of the respective compounds at pH 7.5. The lowest concentrations were 2 M for succinate, 5 M for ␣-ketoglutarate, glutarate, NCG, and NAG, and 200 M for glutamate. Imax, maximal current.
